News

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

MS Focus offices closed for Juneteenth

June 18, 2025

The entire staff of MS Focus would like to wish everyone a safe and pleasant holiday.
Learn more

Researchers find evidence of accelerated aging in children with MS

June 16, 2025

First-of-its kind study reveals signs of premature biological aging in teenagers with MS pointing to new treatment possibilities beyond immunosuppression.
Learn more

Gut flora may play larger role than previously thought

June 12, 2025

Study of twins detects bacteria in the small intestine that play a part in the development of MS.
Learn more

Study finds multiple factors may be linked to MS risk

June 09, 2025

Radiologically isolated syndrome may prove crucial to potential diagnosis.
Learn more

Study: Fenebrutinib maintains near-complete suppression of MS disease activity

June 04, 2025

Findings suggest treatment suppresses disability progression for up to two years in people with relapsing MS.
Learn more

Study suggests travel burden reduces treatment adherence

May 29, 2025

Home administration of DMTs may be better option for Medicare beneficiaries.
Learn more

Study spotlights new biomarker for predicting MS progression

May 05, 2025

Discovery makes it possible to identify patients who need more aggressive treatment earlier.
Learn more

New AI model may improve MS diagnostics

May 02, 2025

In more than 87 percent of cases, model correctly identified transition to secondary progressive MS.
Learn more

Treatment may delay disability progression in MS

April 11, 2025

Tolebrutinib phase 3 data suggest benefit on disability progression independent of relapse activity.
Learn more

MS Focus offices closed for Juneteenth

June 18, 2025

The entire staff of MS Focus would like to wish everyone a safe and pleasant holiday.
Learn more

Researchers find evidence of accelerated aging in children with MS

June 16, 2025

First-of-its kind study reveals signs of premature biological aging in teenagers with MS pointing to new treatment possibilities beyond immunosuppression.
Learn more

Gut flora may play larger role than previously thought

June 12, 2025

Study of twins detects bacteria in the small intestine that play a part in the development of MS.
Learn more

Study finds multiple factors may be linked to MS risk

June 09, 2025

Radiologically isolated syndrome may prove crucial to potential diagnosis.
Learn more

Study: Fenebrutinib maintains near-complete suppression of MS disease activity

June 04, 2025

Findings suggest treatment suppresses disability progression for up to two years in people with relapsing MS.
Learn more

Study suggests travel burden reduces treatment adherence

May 29, 2025

Home administration of DMTs may be better option for Medicare beneficiaries.
Learn more

Study spotlights new biomarker for predicting MS progression

May 05, 2025

Discovery makes it possible to identify patients who need more aggressive treatment earlier.
Learn more

New AI model may improve MS diagnostics

May 02, 2025

In more than 87 percent of cases, model correctly identified transition to secondary progressive MS.
Learn more

Treatment may delay disability progression in MS

April 11, 2025

Tolebrutinib phase 3 data suggest benefit on disability progression independent of relapse activity.
Learn more

AI tool can track effectiveness of MS treatments

April 10, 2025

New tool may be able to extract key information from MRI scans acquired during patient care.
Learn more

FDA accepts tolebrutinib for priority review for patients with MS

March 26, 2025

Tolebrutinib may have the potential to be the first therapy to target smoldering neuroinflammation.
Learn more

Study suggests cognitive performance, fall-risk link

March 25, 2025

Findings deepen understanding of fall risk, a major safety and significant quality-of-life concern for people with MS.
Learn more

High dose vitamin D may reduce disease activity

March 19, 2025

Researchers claim findings warrant further investigation.
Learn more

Genetic and phenotypic risk score model may predict MS

March 11, 2025

The researchers argue they established a well-performing risk score model for MS based on genetic burden alone, and demonstrate the potential utility of phenotype-based risk scoring.
Learn more

Study: Ketogenic diet alters immune and metabolic landscape in MS

March 07, 2025

Researchers said their findings support the immunomodulatory potential of ketogenic diets in MS.
Learn more

High dietary fish intake may slow disability progression in MS

March 03, 2025

Anti-inflammatory, neuroprotective properties of nutrients found in fish may be key. Findings underscore potential importance of diet in managing MS, say researchers.
Learn more

Pregnancy may increase risk of mental illness in people with MS

January 24, 2025

Researchers said findings emphasize need for early and preventive treatment of mental illness.
Learn more

Mobility may stumble with menopause in MS, according to study

January 14, 2025

Researchers argue menopause represents a unique factor in MS progression.
Learn more


Show More News